The expression of ALDH1A1 was positively correlated with the stage and grade of lung tumors and related to a poor prognosis for patients with early-stage lung cancer, which suggested that ALDH1A1 could be a potential prognostic factor and therapeutic target for the treatment of patients with lung cancer. This evidence concerns the gene ALDH1A1 and lung carcinoma.